News Release - June 16, 2008

NEW ORLEANS--(HSMN NewsFeed)--Royal Philips Electronics (NYSE: PHG; AEX: PHI) today announced the release of the new Philips BrightView XCT, designed specifically to meet the needs of nuclear medicine. The BrightView XCT integrates Philips BrightView SPECT in a co-planar design with advanced flat-detector X-ray CT technology to acquire low dose, high resolution CT images and to improve registration confidence. This is the first time a flat panel X-ray detector will be used for CT imaging in nuclear medicine. This system, along with the new GEMINI TF Big Bore and new NM Application Portfolio on the Extended Brilliance Workspace, is currently on display at the Society of Nuclear Medicine (SNM) annual meeting.

“Philips is devoting substantial resources toward expanding its nuclear medicine portfolio to meet the needs of our customers,” said Jay Mazelsky, senior vice president, Nuclear Medicine, for Philips Healthcare. “At SNM 2008, we are adding to our history of clinical innovation with several new products, demonstrating how Philips is combining design, technology and intelligence in ways specifically designed to help our customers do more for their patients in general nuclear medicine studies and throughout the cycle of care in oncology and cardiology.”

The BrightView XCT features technological advances that can enable low patient dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times. This offers clinical advantages particularly in cardiology studies, the top procedure in nuclear medicine. In addition, the co-planar SPECT and CT capabilities limit, and in some cases eliminate, the need to move the table between scans. Reduced movement can help improve patient comfort and allow for more confidence in image registration, the process of comparing, matching and superimposing the SPECT and CT images on one another for analysis. The BrightView XCT is also the only scalable SPECT and SPECT/CT system that fits into a 12’x15.5’ room and does not require special certification for nuclear medicine technicians.

“The BrightView XCT is very helpful in the interpretation of nuclear medicine images by providing high quality localization and attenuation correction,” said Dr. Richard Myers, chairman of the Nuclear Medicine Division at Radiological Association of Sacramento. “The quality of the SPECT images is noticeably improved with the addition of attenuation and scatter correction.”

Expanding on its leadership in time-of-flight imaging, Philips is also showcasing the first ever large bore PET/CT system—the Philips GEMINI TF Big Bore. With a full 85 cm bore for PET and CT scans, the new system allows for positioning flexibility and has a rigid table design to meet the accuracy requirements for treatment planning. The GEMINI TF Big Bore allows clinicians to image patients in the same position they are treated, expanding PET/CT capabilities beyond diagnosis, staging and follow-up to include therapy planning. The system combines Philips’ GEMINI TF time-of-flight PET imaging technologies with its Brilliance Big Bore CT localization to consolidate radiation oncology procedures, increase potential for greater accuracy and improve scheduling. It is the first system that offers tools and protocols to easily integrate PET functional images into radiation oncology, helping to consolidate procedures while maintaining premium image quality.

“With more than 90 GEMINI TF systems installed, we have substantial experience with time-of-flight imaging. The GEMINI TF Big Bore, an evolution enabled by time-of-flight imaging, expands the clinical utility of PET/CT in oncology care, combining the capabilities of a state-of-the-art CT simulator and a premium PET/CT system into one product,” said Mazelsky.

The first Philips GEMINI TF Big Bore will be installed later this year in the Perelman Center for Advanced Medicine as part of the University of Pennsylvania Health System in conjunction with the Abramson Cancer Center and the Roberts Proton Therapy Center.

At SNM 2008, Philips is also introducing a comprehensive portfolio of nuclear medicine applications on the powerful Extended Brilliance Workspace (EBW). Intuitive and easy to use, the Nuclear Medicine Application Portfolio provides a common analysis and viewing environment for SPECT, PET and CT, as well as a comprehensive support for hybrid imaging workflow. The offering features hybrid imaging visualization and analysis tools to optimize image quality and streamline workflow. It also includes advanced cardiac quantification software for improved study interpretation and a comprehensive library of organ specific analysis tools to help improve diagnostic confidence and facilitate patient management. Additionally, the new Tumor Tracking application simplifies oncology patient management by providing tools to compare, analyze and track tumor volume and metabolic activity in order to monitor disease over time.

For more information about these products and more, visit Philips at booth #1331 at the SNM annual meeting.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions through the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide. With sales of USD 42.5 billion (E27 billion) in 2007, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at www.philips.com/newscenter.

Source:Royal Philips Electronics

Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.